1.63
1.63 (0%)
As of Feb 14, 2025
Taysha Gene Therapies, Inc. [TSHA]
Source:
Company Overview
Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company focused on advancing AAV-based gene therapies for the treatment of severe monogenic diseases of the central nervous system, or CNS.
Country | United States |
Headquarters | dallas, texas |
Phone Number | ( 214 ) 612-0000 |
Industry | manufacturing |
CEO | Sean Nolan |
Website | www.tayshagtx.com |